Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgae031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Marwa Monier Mahmoud Refaie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Minia University, 61511 El-Minia, Egypt. Hauptthemen laut MEDLINE: Valsartan, Rats, Wistar, Interleukin-6, Reperfusion Injury. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Objectives
Intestinal ischemia reperfusion (IIR) is a critical emergency situation that needs immediate intervention. Small intestine is one of the most sensitive tissues to IR injury and it remains a highly morbid condition, with reported mortality rates ranging from 30% to 90%. Thus, we aimed to evaluate the suspected protective role of sacubitril/valsartan (SAC/VAL) on IIR injury.
Methods
Thirty-two adult male Wistar rats were used in our model and divided into four groups: sham group, SAC/VAL treated group without IIR, IIR group, and SAC/VAL treated group with IIR. SAC/VAL in a dose of 30 mg/kg was administered orally just before induction of IIR. Key findings SAC/VAL significantly ameliorated IIR-induced changes as it decreased malondialdehyde (MDA), tumor necrosis factor alpha (TNFα), angiotensin II (ANG II), interleukin 6 (IL 6), active caspase 3, and signal transducer- and activator-of transcription (STAT1). However, SAC/VAL administration significantly increased antioxidant parameters such as total antioxidant capacity (TAC), superoxide dismutase (SOD), and reduced glutathione (GSH). Moreover, alteration of the histological structure was observed in IIR group that was improved by SAC/VAL.
Conclusions
SAC/VAL prevents IIR-induced damage via modulation of renin angiotensin aldosterone system, antioxidant, anti-apoptotic, anti-inflammatory properties, and regulation of IL6/STAT1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, Minia University, 61511 El-Minia, Egypt.
- Department of Histology and Cell Biology, Faculty of Medicine, Minia University, 61511 El-Minia, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Minia University, 61519 El-Minia, Egypt.
ORCID-Profile: Marwa Monier Mahmoud Refaie, Entesar Farghly Amin, Marwa Nadi Hassan, Rehab Ahmed Rifaai, Asmaa M A Bayoumi, Maha Yehia Kamel
Zitieren
APA
Refaie, M. M. M., Amin, E. F., Hassan, M. N., Rifaai, R. A., Bayoumi, A. M. A., & Kamel, M. Y. (2024). Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae031
Vancouver
Refaie MMM, Amin EF, Hassan MN, Rifaai RA, Bayoumi AMA, Kamel MY. Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae031
BibTeX
@article{Refaie2024,
author = {Refaie, Marwa Monier Mahmoud and Amin, Entesar Farghly and Hassan, Marwa Nadi and Rifaai, Rehab Ahmed and Bayoumi, Asmaa M A and Kamel, Maha Yehia},
title = {Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgae031}
}
EUVIMED